• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Hemophilia B

Hemophilia B - 26 Studies Found

Completed : Study Evaluating BENEFIX in Previously Treated Patients With Hemophilia B
: Hemophilia B
: 2007-12-21
: Drug: Recombinant Factor IX Coagulation Benefix IV each 12 hours for 2 a 5 days
Completed : Study Comparing On-Demand Treatment With Two Prophylaxis Regimens Of BeneFIX In Patients With Severe Hemophilia B
: Hemophilia B
: 2006-08-14
:
  • Drug: Recombinant Coagulation Factor IX (BeneFIX)

Active, not recruiting : Safety and Dose Finding Study of DTX101 (AAVrh10FIX) in Adults With Moderate/Severe to Severe Hemophilia B
: Hemophilia B
: 2015-11-23
: Genetic: AAVrh10FIX non-replicating recombinant AAVrh10 encoding human FIX (hFIX)
Completed : Long-Term Safety, Tolerability, and Efficacy of DTX101 (AAVrh10FIX) in Adults With Moderate/Severe to Severe Hemophilia B
: Hemophilia B
: 2016-11-21
Active, not recruiting : Study of Recombinant Factor IX Product, IB1001, in Previously Treated Pediatric Subjects With Hemophilia B
: Hemophilia B
: 2011-01-06
: Drug: Recombinant factor IX Product, IB1001 On-Demand or Prophylaxis
Completed : Efficacy and Safety of AlphaNine Versus BeneFIX in Patients With Severe Hereditary Haemophilia B
: Hemophilia B
: 2017-03-16
: Drug: BeneFIX BeneFIX is a recombinant FIX that contains nonacog alfa, reconstituted in solvent and admi
Active, not recruiting : Open-Label Single Ascending Dose of Adeno-associated Virus Serotype 8 Factor IX Gene Therapy in Adults With Hemophilia B
: Hemophilia B
: 2012-08-27
: Biological: AskBio009 Single dose IV injection Other
Completed : Post Marketing Surveillance To Observe Safety and Efficacy Of BeneFIX In Patients With Hemophilia B
: Hemophilia B
: 2007-06-07
: Drug: BeneFIX (coagulation factor IX (recombinant)) BeneFIX will be administered according to physician'
Completed : Dose-Escalation Study Of A Self Complementary Adeno-Associated Viral Vector For Gene Transfer in Hemophilia B
: Hemophilia B
: 2009-09-16
:
  • Genetic: Gene Transfer Periphe

Completed : Post Marketing Study in Haemophilia B Patients Using Nonafact® (Human Coagulation Factor IX)
: Hemophilia B
: 2005-08-30
: Drug: human coagulation Factor IX Other Name: Nonafact
Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.